Many companies are working on vaccines, but these are the three that experts say are closest to being tested, approved and available to the U.S. public.
Finding a vaccine for coronavirus has become a public health priority, and pharmaceutical companies and researchers across the country are hard at work on different contenders.
While many companies are working on vaccines, below are two potential vaccines and one"passive vaccine" that experts tell NBC News are closest to being tested, approved and available to the U.S. public.Moderna's mRNA-1273Moderna Inc. of Cambridge, Massachusetts, has already begun Phase I human testing of its mRNA-1273 at Kaiser Permanente Washington Health Research Institute in Seattle. The test has enrolled 45 healthy adults ages 18 to 55.
Subjects get an injection on days 1 and 29 and will be followed for 12 months after the second injection.Regeneron's REGN3048-3051Regeneron Pharmaceuticals of Tarrytown, New York, is working on an antibody treatment that uses the virus itself. The company genetically modifies mice to have human immune systems and then exposes them to part of the virus. The mice then build up antibodies to fight the virus.
Regeneron's drug could be used as a treatment for those who are already infected, but according to the company it could also be used as a preventive measure for the healthy, like a vaccine. Such drugs are sometimes referred to as"passive" vaccines.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
I Was The First Person To Test The Coronavirus VaccineThe race for a vaccine for the novel coronavirus, officially termed COVID-19, is on. As the number of cases all over the world continues to rise, pharmaceutical companies and academic institutions are scrambling to create an immunization shot that might halt the spread of the virus.So yesterday, at 8
続きを読む »
Here are 3 vaccines in development to fight coronavirusMany companies are working on coronavirus vaccines, but these are the three that experts say are closest to being tested, approved and available to the U.S. public.
続きを読む »
'Race against the clock': Scientists testing if existing drugs can fight novel coronavirus right nowDozens of already-existing drugs may be able to treat the novel coronavirus.
続きを読む »
An HIV drug failed to help patients with severe cases of COVID-19, according to disappointing results from one of the first coronavirus drug trialsKaletra is one of several existing drugs that are being tested as repurposed coronavirus treatments.
続きを読む »
3 biotechs are rapidly making coronavirus vaccine progress - Business InsiderPharmaceutical companies will likely pursue tie-ups with biotech firms post-coronavirus due to their ability to develop novel treatments
続きを読む »
Coronavirus trial vaccine participant says he wants to help the worldNeal Browning is one of 45 healthy individuals who has volunteered for a coronavirus vaccine trial in Washington state. 'If I'm healthy enough to be able to contribute research and hoping you find a vaccine sooner than later, why wouldn't I?'
続きを読む »